Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Drug Discovery Informatics Market by Application (Drug Discovery, Drug Development), by Function (Sequencing and Target Data Analysis, Library and Database Preparation, Docking, Molecular Modelling, Others), by End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

A07074

Pages: 280

Charts: 51

Tables: 124

Drug Discovery Informatics Market Research, 2032

The global drug discovery informatics market size was valued at $2.9 billion in 2022, and is projected to reach $7.9 billion by 2032, growing at a CAGR of 10.5% from 2023 to 2032. Major factors driving the growth of the market are increased research spending on informatics by biotechnology and pharmaceutical companies coupled with the growing demand and support for rare disease and orphan drug research. For instance, according to National Center for Science and Engineering Statistics in 2022, the research and development spending by academic institutions totaled $97.8 billion in FY 2022, an increase of $8.0 billion from FY 2021. Such an increase in research spending highlights the demand and pace at which the market is growing.

Drug discovery is a process which requires a huge amount of information. Drug discovery informatics includes databases of various molecules and drugs which are used by various pharmaceutical companies to perform their research. Various software are used to manage and filter the databases. Drug discovery informatics makes use of IT platforms, vital information and other processes to improve and rise over challenges. This sector used modern improvised technology like data storage, processing the data, managing and analyzing it.

Key Takeaways

  • By application, the drug discovery segment dominated the global market in 2022.
  • By function, the sequencing and target data analysis segment acquired a major share in the global market in 2022.
  • By end use, the pharmaceutical companies segment acquired a major share in the global market in 2022.
  • By region, North America dominated the market in terms of revenue in 2022.

Market Dynamics

The market is primarily driven by an increase in focus in drug discovery by utilizing informatics software and the advancements in high performance computing and web services. Additionally, the increasing adoption of in silico modelling tools and rising demand for innovative drug molecules will further drive the market growth.

However, high costs associated with the informatics software might restrain the market growth. Further, the growth in biotechnology and biologics industry especially in emerging markets will create many lucrative opportunities in the market.

The market's expansion is further propelled by the introduction of advanced information technology solutions in drug discovery, intensifying competition among industry participants. For instance, Certara, Inc. unveiled the Simcyp Physiologically based Pharmacokinetic (PBPK) Simulator version 20, which offers new models for assessing drug action during pregnancy and lactation. This aids in making critical decisions concerning optimizing medicine safety and efficacy profiles.

Moreover, there is a growing inclination among companies to embrace informatics solutions to streamline and expedite the drug discovery process. Curve Therapeutics Ltd. implemented the CDD Vault platform to manage its genetically encoded Microcycle platform. This hosted platform provides secure data management and facilitates seamless real-time data sharing, fostering collaborative discoveries across the pharmaceutical, biotechnology, and academic sectors.

The ongoing global endeavors in COVID-19 drug discovery have also contributed to the market's expansion. Scientists have utilized in silico tools and virtual screening techniques to identify potential drug candidates targeting viral proteins and human ACE2 receptors. Additionally, companies are developing web services and solutions tailored specifically for various stages of drug development related to COVID-19. For example, the IBM Visual Molecular Explorer platform has been employed to explore a curated set of molecules targeting the SARS-CoV-2 virus, enabling the sharing of AI-generated artifacts, and aiding in the design of optimal medicines.

Segments Overview

The drug discovery informatics market share is segmented into application, function, end user, and region. Based on application, the market is segmented into drug discovery and drug development. Based on function, the market is segmented into sequencing and target data analysis, library, and database preparation, docking, molecular modelling, and others. Based on end users, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, and other end users. Region wise, the drug discovery informatics market size is segmented into North America, Europe, Asia-Pacific, and LAMEA.

By Application

By application segment, the drug discovery dominated the drug discovery informatics market share in 2022 and is expected to continue this trend during the drug discovery informatics market forecast period. Drug discovery is growing significantly due to the increased research spending and the utilization of artificial intelligence in drug discovery processes. For instance, in 2022, Iktos, announced their collaboration with Teijin Pharma Limited to evolve Artificial Intelligence for small molecules drug discovery.

[APPLICATIONGRAPH]

By Function

By function, the sequencing and target data analysis segment dominated the market in 2022 and is expected continue this trend during the forecast period. Bioinformatic solutions play a crucial role in building primary and secondary databases containing nucleic acids, proteins, and other biomolecule sequences. Informatics software is utilized to efficiently mine and store genome sequencing data, enabling the identification of genes and targeted proteins. This process greatly aids in the development of potential drugs.

[FUNCTIONGRAPH]

By End User

By end use, the pharmaceutical companies segment dominated the market in 2022. Pharmaceutical companies are using informatics software extensively for pre-clinical research, target identification, compound screening and lead identification. Such increased usage for varied drug discovery applications will further drive the drug discovery informatics market growth.

[ENDUSERGRAPH]

By Region

By region, North America dominated the market in 2022 and is expected to continue this trend during the forecast period. This is due to the presence of well established CROs and rise in R&D expenditure by pharmaceutical and biopharmaceutical companies. However, Asia-Pacific is expected to grow with a faster CAGR during the analysis period. This is mainly due to the rapid growth rate in pharmaceutical and biologics industry coupled with the less stringent regulations for drug discovery process.

[REGIONGRAPH]

Competitive Analysis

Major players have adopted partnership and collaboration as their main strategy. For instance, in May 2023, Google Cloud announced two new AI powered life science solutions to accelerate drug discovery and precision medicine for pharmaceutical firms, biotechnology companies and public sector organizations.

Recent Developments in Drug Discovery Informatics Industry

  • In January 2022, Discngine announced a strategic partnership with ChemAxon. This partnership will help both the companies streamline pharma and biotech research involving complex biomolecular structural data.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the drug discovery informatics market analysis from 2022 to 2032 to identify the prevailing drug discovery informatics market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the drug discovery informatics industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global drug discovery informatics market trends, key players, market segments, application areas, and market growth strategies.

 Key Market Segments

  • By Application
    • Drug Discovery
    • Drug Development
  • By Function
    • Sequencing and Target Data Analysis
    • Library and Database Preparation
    • Docking
    • Molecular Modelling
    • Others
  • By End User
    • Biotechnology Companies
    • Pharmaceutical Companies
    • Contract Research Organizations
    • Other End Users
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Certara, Inc.
  • Oracle Corporation
  • Thermo Fisher Scientific Inc.
  • Accenture
  • Jubilant Pharmova
  • Albany Molecular Research, Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

    • 3.4. Market dynamics

      • 3.4.1. Drivers

      • 3.4.2. Restraints

      • 3.4.3. Opportunities

  • CHAPTER 4: DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Drug Discovery

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Drug Development

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

  • CHAPTER 5: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Sequencing and Target Data Analysis

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Library and Database Preparation

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Docking

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

    • 5.5. Molecular Modelling

      • 5.5.1. Key market trends, growth factors and opportunities

      • 5.5.2. Market size and forecast, by region

      • 5.5.3. Market share analysis by country

    • 5.6. Others

      • 5.6.1. Key market trends, growth factors and opportunities

      • 5.6.2. Market size and forecast, by region

      • 5.6.3. Market share analysis by country

  • CHAPTER 6: DRUG DISCOVERY INFORMATICS MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Biotechnology Companies

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Pharmaceutical Companies

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Contract Research Organizations

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

    • 6.5. Other End Users

      • 6.5.1. Key market trends, growth factors and opportunities

      • 6.5.2. Market size and forecast, by region

      • 6.5.3. Market share analysis by country

  • CHAPTER 7: DRUG DISCOVERY INFORMATICS MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by Application

      • 7.2.3. Market size and forecast, by Function

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Market size and forecast, by Application
          • 7.2.5.1.2. Market size and forecast, by Function
          • 7.2.5.1.3. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Market size and forecast, by Application
          • 7.2.5.2.2. Market size and forecast, by Function
          • 7.2.5.2.3. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Market size and forecast, by Application
          • 7.2.5.3.2. Market size and forecast, by Function
          • 7.2.5.3.3. Market size and forecast, by End User

    • 7.3. Europe

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by Application

      • 7.3.3. Market size and forecast, by Function

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Market size and forecast, by Application
          • 7.3.5.1.2. Market size and forecast, by Function
          • 7.3.5.1.3. Market size and forecast, by End User
        • 7.3.5.2. France
          • 7.3.5.2.1. Market size and forecast, by Application
          • 7.3.5.2.2. Market size and forecast, by Function
          • 7.3.5.2.3. Market size and forecast, by End User
        • 7.3.5.3. UK
          • 7.3.5.3.1. Market size and forecast, by Application
          • 7.3.5.3.2. Market size and forecast, by Function
          • 7.3.5.3.3. Market size and forecast, by End User
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Market size and forecast, by Application
          • 7.3.5.4.2. Market size and forecast, by Function
          • 7.3.5.4.3. Market size and forecast, by End User
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Market size and forecast, by Application
          • 7.3.5.5.2. Market size and forecast, by Function
          • 7.3.5.5.3. Market size and forecast, by End User
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Market size and forecast, by Application
          • 7.3.5.6.2. Market size and forecast, by Function
          • 7.3.5.6.3. Market size and forecast, by End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key market trends, growth factors and opportunities

      • 7.4.2. Market size and forecast, by Application

      • 7.4.3. Market size and forecast, by Function

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Market size and forecast, by Application
          • 7.4.5.1.2. Market size and forecast, by Function
          • 7.4.5.1.3. Market size and forecast, by End User
        • 7.4.5.2. China
          • 7.4.5.2.1. Market size and forecast, by Application
          • 7.4.5.2.2. Market size and forecast, by Function
          • 7.4.5.2.3. Market size and forecast, by End User
        • 7.4.5.3. Australia
          • 7.4.5.3.1. Market size and forecast, by Application
          • 7.4.5.3.2. Market size and forecast, by Function
          • 7.4.5.3.3. Market size and forecast, by End User
        • 7.4.5.4. India
          • 7.4.5.4.1. Market size and forecast, by Application
          • 7.4.5.4.2. Market size and forecast, by Function
          • 7.4.5.4.3. Market size and forecast, by End User
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Market size and forecast, by Application
          • 7.4.5.5.2. Market size and forecast, by Function
          • 7.4.5.5.3. Market size and forecast, by End User
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Market size and forecast, by Application
          • 7.4.5.6.2. Market size and forecast, by Function
          • 7.4.5.6.3. Market size and forecast, by End User

    • 7.5. LAMEA

      • 7.5.1. Key market trends, growth factors and opportunities

      • 7.5.2. Market size and forecast, by Application

      • 7.5.3. Market size and forecast, by Function

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Market size and forecast, by Application
          • 7.5.5.1.2. Market size and forecast, by Function
          • 7.5.5.1.3. Market size and forecast, by End User
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Market size and forecast, by Application
          • 7.5.5.2.2. Market size and forecast, by Function
          • 7.5.5.2.3. Market size and forecast, by End User
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Market size and forecast, by Application
          • 7.5.5.3.2. Market size and forecast, by Function
          • 7.5.5.3.3. Market size and forecast, by End User
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Market size and forecast, by Application
          • 7.5.5.4.2. Market size and forecast, by Function
          • 7.5.5.4.3. Market size and forecast, by End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product mapping of top 10 player

    • 8.4. Competitive dashboard

    • 8.5. Competitive heatmap

    • 8.6. Top player positioning, 2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Oracle Corporation

      • 9.1.1. Company overview

      • 9.1.2. Key executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

      • 9.1.7. Key strategic moves and developments

    • 9.2. Accenture

      • 9.2.1. Company overview

      • 9.2.2. Key executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

      • 9.2.7. Key strategic moves and developments

    • 9.3. Thermo Fisher Scientific

      • 9.3.1. Company overview

      • 9.3.2. Key executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

      • 9.3.7. Key strategic moves and developments

    • 9.4. Certara, Inc.

      • 9.4.1. Company overview

      • 9.4.2. Key executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

      • 9.4.7. Key strategic moves and developments

    • 9.5. Albany Molecular Research, Inc.

      • 9.5.1. Company overview

      • 9.5.2. Key executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

      • 9.5.7. Key strategic moves and developments

    • 9.6. Jubilant Pharmova

      • 9.6.1. Company overview

      • 9.6.2. Key executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

      • 9.6.7. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 01. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 02. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY REGION, 2022-2032 ($MILLION)
    TABLE 03. DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
    TABLE 04. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 05. DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY REGION, 2022-2032 ($MILLION)
    TABLE 06. DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY REGION, 2022-2032 ($MILLION)
    TABLE 07. DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2022-2032 ($MILLION)
    TABLE 08. DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY REGION, 2022-2032 ($MILLION)
    TABLE 09. DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
    TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 11. DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
    TABLE 12. DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
    TABLE 13. DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
    TABLE 14. DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
    TABLE 15. DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2022-2032 ($MILLION)
    TABLE 16. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 17. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 18. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 19. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 20. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 21. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 22. U.S. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 23. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 24. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 25. CANADA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 26. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 27. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 29. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 30. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 31. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 32. EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 33. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 34. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 35. GERMANY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 36. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 37. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 38. FRANCE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 39. UK DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 40. UK DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 41. UK DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 42. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 43. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 44. ITALY DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 45. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 46. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 47. SPAIN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 48. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 49. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 50. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 51. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 52. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 53. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 54. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 55. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 56. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 57. JAPAN DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 58. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 59. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 60. CHINA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 61. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 64. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 65. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 66. INDIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 67. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 68. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 69. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 70. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 71. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 72. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 73. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 74. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 75. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 76. LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 77. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 78. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 79. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 80. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 81. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 82. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 83. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 84. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 85. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 86. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 87. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022-2032 ($MILLION)
    TABLE 88. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 89. ORACLE CORPORATION: KEY EXECUTIVES
    TABLE 90. ORACLE CORPORATION: COMPANY SNAPSHOT
    TABLE 91. ORACLE CORPORATION: PRODUCT SEGMENTS
    TABLE 92. ORACLE CORPORATION: SERVICE SEGMENTS
    TABLE 93. ORACLE CORPORATION: PRODUCT PORTFOLIO
    TABLE 94. ORACLE CORPORATION: KEY STRATERGIES
    TABLE 95. ACCENTURE: KEY EXECUTIVES
    TABLE 96. ACCENTURE: COMPANY SNAPSHOT
    TABLE 97. ACCENTURE: PRODUCT SEGMENTS
    TABLE 98. ACCENTURE: SERVICE SEGMENTS
    TABLE 99. ACCENTURE: PRODUCT PORTFOLIO
    TABLE 100. ACCENTURE: KEY STRATERGIES
    TABLE 101. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
    TABLE 102. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
    TABLE 103. THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
    TABLE 104. THERMO FISHER SCIENTIFIC: SERVICE SEGMENTS
    TABLE 105. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
    TABLE 106. THERMO FISHER SCIENTIFIC: KEY STRATERGIES
    TABLE 107. CERTARA, INC.: KEY EXECUTIVES
    TABLE 108. CERTARA, INC.: COMPANY SNAPSHOT
    TABLE 109. CERTARA, INC.: PRODUCT SEGMENTS
    TABLE 110. CERTARA, INC.: SERVICE SEGMENTS
    TABLE 111. CERTARA, INC.: PRODUCT PORTFOLIO
    TABLE 112. CERTARA, INC.: KEY STRATERGIES
    TABLE 113. ALBANY MOLECULAR RESEARCH, INC.: KEY EXECUTIVES
    TABLE 114. ALBANY MOLECULAR RESEARCH, INC.: COMPANY SNAPSHOT
    TABLE 115. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT SEGMENTS
    TABLE 116. ALBANY MOLECULAR RESEARCH, INC.: SERVICE SEGMENTS
    TABLE 117. ALBANY MOLECULAR RESEARCH, INC.: PRODUCT PORTFOLIO
    TABLE 118. ALBANY MOLECULAR RESEARCH, INC.: KEY STRATERGIES
    TABLE 119. JUBILANT PHARMOVA: KEY EXECUTIVES
    TABLE 120. JUBILANT PHARMOVA: COMPANY SNAPSHOT
    TABLE 121. JUBILANT PHARMOVA: PRODUCT SEGMENTS
    TABLE 122. JUBILANT PHARMOVA: SERVICE SEGMENTS
    TABLE 123. JUBILANT PHARMOVA: PRODUCT PORTFOLIO
    TABLE 124. JUBILANT PHARMOVA: KEY STRATERGIES

  • LIST OF FIGURES

  • FIGURE 01. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032
    FIGURE 02. SEGMENTATION OF DRUG DISCOVERY INFORMATICS MARKET,2022-2032
    FIGURE 03. TOP IMPACTING FACTORS IN DRUG DISCOVERY INFORMATICS MARKET
    FIGURE 04. TOP INVESTMENT POCKETS IN DRUG DISCOVERY INFORMATICS MARKET (2023-2032)
    FIGURE 05. BARGAINING POWER OF SUPPLIERS
    FIGURE 06. BARGAINING POWER OF BUYERS
    FIGURE 07. THREAT OF SUBSTITUTION
    FIGURE 08. THREAT OF SUBSTITUTION
    FIGURE 09. COMPETITIVE RIVALRY
    FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11. DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2022 AND 2032(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY, BY COUNTRY 2022 AND 2032(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
    FIGURE 14. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2022 AND 2032(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING AND TARGET DATA ANALYSIS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY AND DATABASE PREPARATION, BY COUNTRY 2022 AND 2032(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY 2022 AND 2032(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY 2022 AND 2032(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 20. DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2022 AND 2032(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 25. DRUG DISCOVERY INFORMATICS MARKET BY REGION, 2022 AND 2032(%)
    FIGURE 26. U.S. DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 27. CANADA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 28. MEXICO DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 29. GERMANY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 30. FRANCE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 31. UK DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 32. ITALY DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 33. SPAIN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 34. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 35. JAPAN DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 36. CHINA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 37. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 38. INDIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 39. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 40. REST OF ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 41. BRAZIL DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 42. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 43. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 44. REST OF LAMEA DRUG DISCOVERY INFORMATICS MARKET, 2022-2032 ($MILLION)
    FIGURE 45. TOP WINNING STRATEGIES, BY YEAR (2023-2023)
    FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT (2023-2023)
    FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY (2023-2023)
    FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 49. COMPETITIVE DASHBOARD
    FIGURE 50. COMPETITIVE HEATMAP: DRUG DISCOVERY INFORMATICS MARKET
    FIGURE 51. TOP PLAYER POSITIONING, 2022

Purchase Full Report of
Drug Discovery Informatics Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved